Thus, LAT-1 expression has been associated with tumor behavior and prognosis in certain cancers, including non-small cell lung cancer [6], prostate cancer [7], melanoma of the skin [8], breast cancer [9], gastric cancer [10], and renal cell carcinoma [11]. Here, SLC7A5 is linked to hereditary clear cell renal cell carcinoma.